MT1X and esophageal squamous cell carcinoma: It is hoped that future studies will include more molecular pathology and clinical information, and that basic research will be used to analyse the interaction between MT1X and ESCC targets in depth, in order to more fully explore the close association between the lysosomal pathway and ESCC.